[1] | Skinsnes O. Notes from the History of leprosy. International journal of leprosy. 1973; 41(2): 1. |
|
[2] | Browne S. Some Aspects of the History of Leprosy: The Leprosie of Yesterday [Internet]. Journals.sagepub.com. 1975 [cited 25 May 2020]. Available from: https://journals.sagepub.com/doi/pdf/10.1177/00359157750680080. |
|
[3] | Bennett BH, Parker DL. and Robson M. Leprosy: steps along the journey of eradication. Public Health Reports, 2008, 123(2), 198-205. |
|
[4] | Monot M, Honoré N, Garnier T, Araoz R, Coppée JY, Lacroix C, et al. On the origin of leprosy. Science; 2005, 308(5724): 1040-1042. |
|
[5] | Robbins G, Tripathy VM, Misra VN, Mohanty RK, Shinde VSG, Kelsey M. et al. "Ancient Skeletal Evidence for Leprosy in India (2000 B.C.)" PLOS ONE. 2000, 4(5): e5669. |
|
[6] | Trautman JR. A brief history of Hansen's disease. Bulletin of the New York Academy of Medicine. 1984;60(7):689-695. |
|
[7] | Venita J. The legacy of Armauer Hansen. A portrait in history. Archives of Pathology and Laboratory Medicine 2000; (4)124: 496-497. |
|
[8] | World Health Organisation. Leprosy fact sheet. 2000 Available from: https://www.who.int/news-room/fact-sheets/detail/leprosy (accessed 25/5/2020). |
|
[9] | Rao P N. Global leprosy strategy 2016-2020: Issues and concerns. Indian Journal of Dermatology, Venereology and Leprology [serial online (cited 2020 May 17) 2017; 83: 4-6. |
|
[10] | Victor SS, Carlos DFS, Paulo RS, Martin F and Luis E. Cuevas Leprosy: why does it persist among us? Expert Review of Anti-infective Therapy, 2020. |
|
[11] | World Health Organisation, Facts Sheet on Leprosy, 2019, (Cited 2020 June 02)Available at: https://www.who.int/en/news-room/fact-sheets/detail/leprosy. |
|
[12] | World Health Organisation, Neglected Tropical Diseases: News, 2019 ,(Cited 2020 June 02) Available at: https://www.who.int/neglected_diseases/news/Leprosy-new-data- show-steady-decline-in-new-cases/en/. |
|
[13] | Ploemacher T, Faber WR, Menke H, Rutten V, Pieters T. Reservoirs and transmission routes of leprosy; A systematic review. PLoS Neglected Tropical Diseases. 2020; 14(4): e0008276. Published 2020 Apr 27. |
|
[14] | World Health Organisation, Global Health Data Repository: Leprosy- Number of new leprosy cases Data per country (Cited 2020 May 24th). |
|
[15] | Oliveira IVP, Deps PD, Antunes JMAP. Armadillos and leprosy: from infection to biological model. Revista do Instituto de Medicina Tropical de Sao Paulo. 2019; 61: e44. Published 2019 Sep 12. |
|
[16] | Ramesh MB and Chaitra P. Leprosy: An Overview of Pathophysiology, Interdisciplinary Perspectives on Infectious Disease 2012: 181089. Published online 2012 sep 4. |
|
[17] | Marcellus F. Leprosy - an overview of clinical features, diagnosis, and treatment, Journal of the German society of dermatology August 2017 vol 15(08), 801-827. |
|
[18] | Job CK, Jayakumar J, Kearney M, Gillis TP. Transmission of leprosy: A study of skin and nasal secretions of household contacts of leprosy patients using PCR. The American Journal of Tropical Medicine and Hygiene. 2008; 78(3): 518-521. |
|
[19] | Satapathy J, Kar BR, Job CK. Presence of Mycobacterium leprae in epidermal cells of lepromatous skin and its significance. Indian Journal of Dermatology, Venereology and Leprology. 2005; 71(4): 267-269. |
|
[20] | Bruce S, Schroeder TL, Ellner K, Rubin H, Williams T, Wolf JE. Armadillo exposure and Hansen’s disease: An epidemiologic survey in southern Texas. Journal of the American Academy of Dermatology. 2000; 43(2): 223-228S. |
|
[21] | Rambukkana, A, Zanazzi G, Tapinos, N., and Salzer, J L “Contact-dependent demyelination by Mycobacterium leprae in the absence of immune cells,” Science, 2002, 296(5569), pp. 927-931. |
|
[22] | Marques MAM, Antônio VL, Sarno EN, Brennan PJ, and Pessolani MCV, “Binding of α2-laminins by pathogenic and non-pathogenic mycobacteria and adherence to Schwann cells,” Journal of Medical Microbiology, 2001, 50(1), pp. 23-28. |
|
[23] | Tapinos N, Ohnishi M, and Rambukkana A, “ErbB2 receptor tyrosine kinase signaling mediates early demyelination induced by leprosy bacilli,” Nature Medicine, 2006, 12(8), pp. 961-966. |
|
[24] | Rambukkana A, Yamada H, Zanazzi G, Mathus T, Salzer JL Yurchenco PD et al., “Role of α-dystroglycan as a Schwann cell receptor for Mycobacterium leprae,” Science, 1998, 282(5396), pp. 2076-2079. |
|
[25] | Ridley DS. and Jopling WH. “Classification of leprosy according to immunity. A five-group system,” International Journal of Leprosy and Other Mycobacterial Diseases,1966, 34(3), pp. 255-273. |
|
[26] | Fajardo TT, “Indeterminate leprosy: a five year study, clinical observations,” International Journal of Leprosy, 1973, Vol 41, p. 576. |
|
[27] | Canizares O, Harman R, Adriaans B. Leprosy. In: Canizares O, Harman R, editors. Clinical Tropical Dermatology. 2nd ed. Boston: Blackwell Scientific; 1992. pp. 165-200. |
|
[28] | Elinav H, Palladas L, Applbaum YH, Gilead L, Moses AE, Cohen-Poradosu R. Plantar ulcers and eyebrow-hair paucity. Clinical Infectious Diseases. 2006; 42(5): 684-685, 722-724. |
|
[29] | Akpolat ND, Akkus A and Kaynak E. An Update on the Epidemiology, Diagnosis and Treatment of Leprosy, (Cited 2020 July 3rd): 2018. |
|
[30] | Sehgal VN and Srivastava G, “Status of histoid leprosy-a clinical, bacteriological, histopathological and immunological appraisal,” Journal of Dermatology, 1987, 14(1), pp. 38-42, 1987. |
|
[31] | Sehgal VN, Tuli MS, and Dube B, “Leprotic nerve abscesses in northern India,” International Journal of Leprosy and Other Mycobacterial Diseases, 1967, 35(1), pp. 60-64. |
|
[32] | Britton W. Leprosy. In: Cohen J, Powderly WG, editors. Infectious Diseases. London: Mosby; 2003. pp. 1507-1513. |
|
[33] | Walker SL. 2020 Leprosy reactions. In Gillis TP (ed), International textbook of leprosy. Accessed 13/6/2020. |
|
[34] | Scollard DM et al. 1993. Epidemiological characteristics of leprosy. International journal of leprosy. Volume 62, No 4. Available from http://ila.ilsl.br/pdfs/v62n4a09.pdf. Accessed 13/6/2020. |
|
[35] | Scollard DM et al. The continuing challenges of leprosy. Clinical microbiology reviews. 2006; 19(2): 338-381. |
|
[36] | Scollard D et al. 2020 Leprosy; epidemiology, microbiology, clinical manifestations and diagnosis. In Baron, E (ed). Uptodate. Accessed 13/6/2020 https://www.uptodate.com/contents/leprosy- epidemiology-microbiology-clinical-manifestations-and- diagnosis?search=diagnosis%20of%20leprosy&source=search_res ult&selectedTitle=1~95&usage_type=default&display_rank=1#H15. |
|
[37] | World health organisation. Guidelines for the diagnosis, treatment and prevention of leprosy. Available from https://apps.who.int/iris/bitstream/handle/10665/274127/97892902 26383-eng.pdf?sequence=10&isAllowed=y. Accessed 13/6/2020. |
|
[38] | National Hansen disease programme. NHDP guide to the management of Hansen disease. Available from https://www.hrsa.gov/sites/default/files/hrsa/hansens- disease/pdfs/hd-guide-management.pdf. Accessed 13/6/2020. |
|
[39] | WHO Study Group on Chemotherapy of Leprosy for Control Programmes & World Health Organization. (1982). Chemotherapy of leprosy for control programmes: report of a WHO study group World Health Organization. https://apps.who.int/iris/handle/10665/38984. Accessed 12/6/2020. |
|
[40] | WHO Expert Committee on Leprosy. WHO Expert Committee on Leprosy: seventh report. WHO Technical Report Series No. 874. Geneva: WHO; 1998. http://www.who.int/iris/handle/10665/42060, Accessed 20th June 2020. |
|
[41] | Guidelines for the diagnosis, treatment and prevention of leprosy. New Delhi: World Health Organization, Regional Office for South-East Asia; https://apps.who.int/iris/bitstream/handle/10665/274127/97892902 26383-eng.pdf?ua=1 Accessed 20th June 2020. |
|